2 terminated, 1 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow acadesine: new trials by email Literature Review of acadesine trials Research Report on acadesine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GFM-Acadesine: A Phase I-II Trial of Acadesine ACADESINE 140mg/kg/d, ACADESINE 210mg/kg/d, ACADESINE 315mg/kg/d - SMD | Phase 1 / Phase 2 | Terminated | Groupe Francophone des Myelodysplasies | 5 | 2013-06-01 | 2016-11-08 |
| The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) Acadesine, Normal Saline - Coronary Artery Bypass, Myocardial Infarction | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 3080 | 2009-04-01 | 2015-10-29 |
| Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients Acadesine - Leukemia, B-Cell, Chronic | Phase 1 / Phase 2 | Completed | Advancell - Advanced In Vitro Cell Technologies, S.A. | 40 | 2007-12-01 | 2011-05-10 |
Leukemia, Lymphocytic, Chronic, B-Cell (1) · Myocardial Infarction (1) · Stroke (1) · Ventricular Dysfunction, Left (1)
Advancell - Advanced In Vitro Cell Technologies, S.A. (1) · Groupe Francophone des Myelodysplasies (1) · Merck Sharp & Dohme LLC (1)
France (2) · Belgium (1) · Spain (1)
Eric Van Den Neste, MD (1) · Pierre Fenaux, MD (1) · Thomas Cluzeau, MD (1)